Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dornase Alfa in COVID-19 Respiratory Insufficiency
NCT05139901Phase 4Terminated
- Sponsor
- University Medical Centre Ljubljana
- Start
- Dec 2021
- Primary completion
- Feb 2023
- Modality
- Replacement Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of dornase alfa in COVID-19 pneumonia, sponsored by University Medical Centre Ljubljana. Started Dec 2021; status: terminated.
02
Drugs
dornase alfa
03
Conditions
COVID-19 pneumonia
Beyond the preview
Go deeper on NCT05139901.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05139901.